These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 23686713)

  • 1. Oxidative stress augments pulmonary hypertension in chronically hypoxic mice overexpressing the oxidized LDL receptor.
    Ogura S; Shimosawa T; Mu S; Sonobe T; Kawakami-Mori F; Wang H; Uetake Y; Yoshida K; Yatomi Y; Shirai M; Fujita T
    Am J Physiol Heart Circ Physiol; 2013 Jul; 305(2):H155-62. PubMed ID: 23686713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress contributes to pulmonary hypertension in the transgenic (mRen2)27 rat.
    DeMarco VG; Habibi J; Whaley-Connell AT; Schneider RI; Heller RL; Bosanquet JP; Hayden MR; Delcour K; Cooper SA; Andresen BT; Sowers JR; Dellsperger KC
    Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2659-68. PubMed ID: 18424632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LOX-1 promotes right ventricular hypertrophy in hypoxia-exposed rats.
    Zhu TT; Zhang WF; Luo P; Qian ZX; Li F; Zhang Z; Hu CP
    Life Sci; 2017 Apr; 174():35-42. PubMed ID: 28259654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin Signaling Through the 5-HT
    Hood KY; Mair KM; Harvey AP; Montezano AC; Touyz RM; MacLean MR
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1361-1370. PubMed ID: 28473438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary hypertension in adult Alk1 heterozygous mice due to oxidative stress.
    Jerkic M; Kabir MG; Davies A; Yu LX; McIntyre BA; Husain NW; Enomoto M; Sotov V; Husain M; Henkelman M; Belik J; Letarte M
    Cardiovasc Res; 2011 Dec; 92(3):375-84. PubMed ID: 21859819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of LR11 Attenuates Hypoxia-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation With Medial Thickening in Mice.
    Jiang L; Konishi H; Nurwidya F; Satoh K; Takahashi F; Ebinuma H; Fujimura K; Takasu K; Jiang M; Shimokawa H; Bujo H; Daida H
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1972-9. PubMed ID: 27493099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron is associated with the development of hypoxia-induced pulmonary vascular remodeling in mice.
    Naito Y; Hosokawa M; Sawada H; Oboshi M; Iwasaku T; Okuhara Y; Eguchi A; Nishimura K; Soyama Y; Hirotani S; Mano T; Ishihara M; Masuyama T
    Heart Vessels; 2016 Dec; 31(12):2074-2079. PubMed ID: 27311944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NADPH oxidase 4 is expressed in pulmonary artery adventitia and contributes to hypertensive vascular remodeling.
    Barman SA; Chen F; Su Y; Dimitropoulou C; Wang Y; Catravas JD; Han W; Orfi L; Szantai-Kis C; Keri G; Szabadkai I; Barabutis N; Rafikova O; Rafikov R; Black SM; Jonigk D; Giannis A; Asmis R; Stepp DW; Ramesh G; Fulton DJ
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1704-15. PubMed ID: 24947524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells.
    Lee WJ; Ou HC; Hsu WC; Chou MM; Tseng JJ; Hsu SL; Tsai KL; Sheu WH
    J Vasc Surg; 2010 Nov; 52(5):1290-300. PubMed ID: 20692795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioactive fraction of Rhodiola algida against chronic hypoxia-induced pulmonary arterial hypertension and its anti-proliferation mechanism in rats.
    Nan X; Su S; Ma K; Ma X; Wang X; Zhaxi D; Ge R; Li Z; Lu D
    J Ethnopharmacol; 2018 Apr; 216():175-183. PubMed ID: 29325918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxic pulmonary hypertension: role of superoxide and NADPH oxidase (gp91phox).
    Liu JQ; Zelko IN; Erbynn EM; Sham JS; Folz RJ
    Am J Physiol Lung Cell Mol Physiol; 2006 Jan; 290(1):L2-10. PubMed ID: 16085672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
    Nave AH; Mižíková I; Niess G; Steenbock H; Reichenberger F; Talavera ML; Veit F; Herold S; Mayer K; Vadász I; Weissmann N; Seeger W; Brinckmann J; Morty RE
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1446-58. PubMed ID: 24833797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dominant negative mutation of the TGF-beta receptor blocks hypoxia-induced pulmonary vascular remodeling.
    Chen YF; Feng JA; Li P; Xing D; Zhang Y; Serra R; Ambalavanan N; Majid-Hassan E; Oparil S
    J Appl Physiol (1985); 2006 Feb; 100(2):564-71. PubMed ID: 16223981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced hypoxic pulmonary vascular remodeling by nitric oxide from the endothelium.
    Ozaki M; Kawashima S; Yamashita T; Ohashi Y; Rikitake Y; Inoue N; Hirata KI; Hayashi Y; Itoh H; Yokoyama M
    Hypertension; 2001 Feb; 37(2):322-7. PubMed ID: 11230292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coenzyme Q10 suppresses oxLDL-induced endothelial oxidative injuries by the modulation of LOX-1-mediated ROS generation via the AMPK/PKC/NADPH oxidase signaling pathway.
    Tsai KL; Chen LH; Chiou SH; Chiou GY; Chen YC; Chou HY; Chen LK; Chen HY; Chiu TH; Tsai CS; Ou HC; Kao CL
    Mol Nutr Food Res; 2011 Sep; 55 Suppl 2():S227-40. PubMed ID: 21812107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MAP kinase kinase kinase-2 (MEKK2) regulates hypertrophic remodeling of the right ventricle in hypoxia-induced pulmonary hypertension.
    Brown RD; Ambler SK; Li M; Sullivan TM; Henry LN; Crossno JT; Long CS; Garrington TP; Stenmark KR
    Am J Physiol Heart Circ Physiol; 2013 Jan; 304(2):H269-81. PubMed ID: 23125215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial ET(B) limits vascular remodelling and development of pulmonary hypertension during hypoxia.
    Kelland NF; Bagnall AJ; Morecroft I; Gulliver-Sloan FH; Dempsie Y; Nilsen M; Yanagisawa M; Maclean MR; Kotelevtsev YV; Webb DJ
    J Vasc Res; 2010; 47(1):16-22. PubMed ID: 19672104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirtuin 3 deficiency does not augment hypoxia-induced pulmonary hypertension.
    Waypa GB; Osborne SW; Marks JD; Berkelhamer SK; Kondapalli J; Schumacker PT
    Am J Respir Cell Mol Biol; 2013 Dec; 49(6):885-91. PubMed ID: 24047466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II type 1 receptor mediates pulmonary hypertension and right ventricular remodeling induced by inhaled nicotine.
    Fried ND; Morris TM; Whitehead A; Lazartigues E; Yue X; Gardner JD
    Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1526-H1534. PubMed ID: 33577434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LOX-1 mediated phenotypic switching of pulmonary arterial smooth muscle cells contributes to hypoxic pulmonary hypertension.
    Zhang W; Zhu T; Wu W; Ge X; Xiong X; Zhang Z; Hu C
    Eur J Pharmacol; 2018 Jan; 818():84-95. PubMed ID: 29069578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.